PHILADELPHIA--(BUSINESS WIRE)--Revitas announced today that it will present at this week’s ACI Chargebacks and Commercial Rebates Conference. According to IDC Health Insights, revenue leakage costs U.S. pharmaceutical companies an estimated $11 billion annually, and inefficient chargeback and rebate processes can add millions to that total. The conference will bring together key industry stakeholders to discuss solutions for the healthcare distribution chain.
